Logo

HTG to Analyze Gene Expression for Takeda Pharmaceutical

Sep 22, 2004

NEW YORK, Sept. 22 (GenomeWeb News) - HTG will provide gene expression analysis services to Takeda Pharmaceutical of Japan, HTG said today.

 

Under the agreement, Tucson, Ariz.-based HTG will use its ArrayPlate technology to analyze samples provided by Takeda, which is based in Osaka.

 

HTG's ArrayPlate contains a Universal Array in each well of a 96-well microplate. The arrays can be programmed using HTG's reagents for the simultaneous measurement of DNA and RNA from the same sample. The assays rely on a quantitative nuclease protection assay.

Breaking News
The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.